DavosBiosciences

Davos BioSciences AG (DBS) was founded as a non-profit Biotech SME and spin-off of CK-CARE (Christine Kühne-Center for Allergy Research and Education) and the Kühne-Foundation, a non-profit foundation of the Kühne Family (Kühne and Nagel, Logistics). Davos BioSciences AG provides a high-quality expertise in biobanking and laboratory services to help pharmaceutical companies in their effort to accelerate and optimize the discovery and development of new therapeutic agents and biomarkers as well as validation of markers and products to meet regulatory requirements. The CK-CARE Registry and Biorepository provides an ideal scientific reference and knowledge background for the activities of Davos BioSciences AG which, in tight collaboration with all members of the CK-CARE consortium and especially with the world-renowned Swiss Institute for Allergy and Asthma Research (SIAF), can benefit from a state-of-the-art technology platform. This certification approach is part of our long-term strategy to provide high-quality samples to the research community”. Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. This labellisation approach is part of our long-term strategy to provide high-quality samples to the research community.